Anti-GALNT11 monoclonal antibody

Pre-made anti-GALNT11 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GALNT11/GALNT11 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0879-Ab-1/ GM-Tg-hg-IP0879-Ab-2Anti-Human GALNT11 monoclonal antibodyHuman
GM-Tg-rg-IP0879-Ab-1/ GM-Tg-rg-IP0879-Ab-2Anti-Rat GALNT11 monoclonal antibodyRat
GM-Tg-mg-IP0879-Ab-1/ GM-Tg-mg-IP0879-Ab-2Anti-Mouse GALNT11 monoclonal antibodyMouse
GM-Tg-cynog-IP0879-Ab-1/ GM-Tg-cynog-IP0879-Ab-2Anti-Cynomolgus/ Rhesus macaque GALNT11 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0879-Ab-1/ GM-Tg-felg-IP0879-Ab-2Anti-Feline GALNT11 monoclonal antibodyFeline
GM-Tg-cang-IP0879-Ab-1/ GM-Tg-cang-IP0879-Ab-2Anti-Canine GALNT11 monoclonal antibodyCanine
GM-Tg-bovg-IP0879-Ab-1/ GM-Tg-bovg-IP0879-Ab-2Anti-Bovine GALNT11 monoclonal antibodyBovine
GM-Tg-equg-IP0879-Ab-1/ GM-Tg-equg-IP0879-Ab-2Anti-Equine GALNT11 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0879-Ab-1/ GM-Tg-hg-IP0879-Ab-2; GM-Tg-rg-IP0879-Ab-1/ GM-Tg-rg-IP0879-Ab-2;
GM-Tg-mg-IP0879-Ab-1/ GM-Tg-mg-IP0879-Ab-2; GM-Tg-cynog-IP0879-Ab-1/ GM-Tg-cynog-IP0879-Ab-2;
GM-Tg-felg-IP0879-Ab-1/ GM-Tg-felg-IP0879-Ab-2; GM-Tg-cang-IP0879-Ab-1/ GM-Tg-cang-IP0879-Ab-2;
GM-Tg-bovg-IP0879-Ab-1/ GM-Tg-bovg-IP0879-Ab-2; GM-Tg-equg-IP0879-Ab-1/ GM-Tg-equg-IP0879-Ab-2
Products NameAnti-GALNT11 monoclonal antibody
Formatmab
Target NameGALNT11
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GALNT11 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0879-Ag-1Recombinant multi-species GLT11/ GALNT11/ GALNAC-T11 protein


    Target information

    Target IDGM-IP0879
    Target NameGALNT11
    Gene ID63917,231050,311952,715572,482809,101083669,534904,100063633
    Gene Symbol and SynonymsA430075I06Rik,E430002F06Rik,GALNAC-T11,GALNACT11,GALNT11
    Uniprot AccessionQ8NCW6,Q6P6V1
    Uniprot Entry NameGLT11_HUMAN,GLT11_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000178234
    Target ClassificationN/A

    The target: GALNT11, gene name: GALNT11, also named as GALNAC-T11, GALNACT11. Enables Notch binding activity and polypeptide N-acetylgalactosaminyltransferase activity. Involved in protein O-linked glycosylation via threonine. Predicted to be located in Golgi membrane. Predicted to be active in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.